Simi Valley’s AeroVironment buys German robotics firm for $45M
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash. AeroVironment also released its second quarter 2021 earnings on Dec. 8, revealing an increase in revenue, but a 71% drop in earnings from the previous Read More →
Read More →Thousand Oaks mayor lauds ‘balanced growth,’ cites new mixed-use project
Thousand Oaks mayor Al Adam gave the annual State of the City address on Dec. 8, centered around three things he said are most important to the city’s growth: jobs, the environment and housing. In his virtual address, Adam said the influx of biotech companies in recent years has been a big win for the Read More →
Read More →MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
Read More →Retailers brace for a pandemic holiday
Small businesses are using the holidays to find new ways to support themselves and their communities.
Read More →New state order could close restaurants, other businesses if ICUs fill up
California Gov. Gavin Newsom announced a revised stay-at-home order on Dec. 3 that is tied to each region of the state’s intensive care capacity. In areas where the ICU capacity falls below 15%, a stay-at-home order will be implemented for three weeks. Under this new order, the state is broken into five regions, with Ventura, Read More →
Read More →Amgen joins new cooperative trials for COVID treatment
With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →
Read More →